• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Krystal Biotech, Inc. - Common Stock (NQ:KRYS)

    260.29 -1.51 (-0.58%)
    Streaming Delayed Price Updated: 11:30 AM EDT, Apr 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 67,355
    Open 261.21
    Bid (Size) 259.51 (100)
    Ask (Size) 262.01 (100)
    Prev. Close 261.80
    Today's Range 257.08 - 262.59
    52wk Range 122.80 - 298.30
    Shares Outstanding 22,205,642
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
    From Palvella Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗
    Viking Therapeutics develops clinical-stage therapies for metabolic and endocrine disorders, aiming to address unmet medical needs. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +5.4%
    +5.4%
    1 Month
    +0.6%
    +0.6%
    3 Month
    +6.4%
    +6.4%
    6 Month
    +44.1%
    +44.1%
    1 Year
    +56.8%
    +56.8%

    More News

    Read More
    News headline image
    This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop ↗
    Via The Motley Fool
    Krystal Biotech Inc (NASDAQ:KRYS) Reports Q4 2025 Earnings Beat and Key Pipeline Advancements ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million ↗
    Via The Motley Fool
    News headline image
    Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Krystal Biotech (KRYS) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Got $300? 2 Biotech Stocks to Buy and Hold Forever ↗
    Via The Motley Fool
    News headline image
    Soleus Adds a Significant Number of Celcuity Shares ↗
    Via The Motley Fool
    News headline image
    Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
    Via The Motley Fool
    News headline image
    Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
    Via The Motley Fool
    News headline image
    Why a Fund Placed a $13 Million Bet on Ambarella Stock Before a 20% Post-Earnings Drop ↗
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    Is IPG Photonics Stock a Buy as One Fund Builds a $9 Million Stake in the Firm? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Fund Has an $8.5 Million Bet on Five9 Despite a 50% One-Year Stock Collapse ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗
    Via The Motley Fool
    News headline image
    Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today ↗
    Via Benzinga
    News headline image
    Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    News headline image
    What's Driving the Market Sentiment Around Krystal Biotech Inc? ↗
    Via Benzinga
    News headline image
    Krystal Biotech (KRYS) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics Earnings

    Frequently Asked Questions

    Is Krystal Biotech, Inc. - Common Stock publicly traded?
    Yes, Krystal Biotech, Inc. - Common Stock is publicly traded.
    What exchange does Krystal Biotech, Inc. - Common Stock trade on?
    Krystal Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Krystal Biotech, Inc. - Common Stock?
    The ticker symbol for Krystal Biotech, Inc. - Common Stock is KRYS on the Nasdaq Stock Market
    What is the current price of Krystal Biotech, Inc. - Common Stock?
    The current price of Krystal Biotech, Inc. - Common Stock is 260.29
    When was Krystal Biotech, Inc. - Common Stock last traded?
    The last trade of Krystal Biotech, Inc. - Common Stock was at 04/07/26 11:30 AM ET
    What is the market capitalization of Krystal Biotech, Inc. - Common Stock?
    The market capitalization of Krystal Biotech, Inc. - Common Stock is 5.78B
    How many shares of Krystal Biotech, Inc. - Common Stock are outstanding?
    Krystal Biotech, Inc. - Common Stock has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.